电子烟相关急性肺实质损伤的系统综述
本文系统综述了电子烟相关急性肺实质损伤的文献,共纳入41篇报告、216例患者。四氢大麻酚是最常被雾化的物质,许多患者BAL中检出维生素E醋酸酯,但尚无确切致病成分。患者表现为咳嗽、呼吸困难、全身及胃肠道症状,影像和病理呈非特异性急性损伤模式;诊断依赖高度怀疑和详细病史,治疗以支持为主,死亡率低,多数患者康复。
要点
- 电子烟相关肺损伤诊断关键在高度怀疑和详细病史。
- 四氢大麻酚是最常雾化物质,维生素E醋酸酯常见于BAL。
- 治疗以支持为主,重症可试用糖皮质激素但证据有限。
核心结论
- 电子烟相关急性肺实质损伤呈非特异性临床、影像和病理模式,诊断依赖高度怀疑和详细病史。
- 治疗以支持为主,死亡率低,多数患者康复;糖皮质激素在重症中 apparent success 但需更严格研究。
研究设计与样本
- 系统综述,回顾科学文献,纳入41篇报告共216例归因于电子烟的肺实质损伤病例。
- 同时概述截至撰稿时电子烟对呼吸健康影响的科学文献。
主要发现
- 四氢大麻酚是最常被雾化的物质。
- 许多受影响个体BAL标本中检出维生素E醋酸酯。
- 截至撰稿时,EVALI爆发已涉及2807例病例和68例死亡。
- 患者表现为咳嗽、呼吸困难、全身症状和胃肠道症状。
- 影像学和组织病理学显示一系列非特异性急性损伤模式。
关键数值与推荐
- 截至撰稿时,EVALI爆发涉及2807例病例和68例死亡。
- 综述纳入41篇报告共216例患者病例。
- 四氢大麻酚是最常雾化物质,维生素E醋酸酯见于许多患者BAL。
- 尚无特定成分或污染物被确切确定为损伤原因。
临床怎么用
- 对疑似电子烟相关肺损伤患者,应详细询问雾化物质使用史并结合高度怀疑以准确诊断。
- 治疗以支持为主;重症患者可试用糖皮质激素,但需更多严格研究明确其作用。
局限性
- 尚无特定成分或污染物被确切确定为损伤原因。
- 糖皮质激素的作用需更严格研究澄清。
- 影像和病理为非特异性急性损伤模式,诊断依赖病史和怀疑。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The outbreak of vaping-related acute lung injury in the United States, named EVALI (e-cigarette or vaping product use associated acute lung injury), has reignited concerns about the health effects of vaping. Initial case reports of vaping-related lung injury date back to 2012, but the ongoing outbreak of EVALI began in the summer of 2019 and has been implicated in 2,807 cases and 68 deaths as of this writing. Review of the scientific literature revealed 216 patient cases that spanned 41 reports of parenchymal lung injury attributed to vaping. In this review, we detail the clinical, radiographic, and pathologic patterns of lung injury that are attributable to vaping and provide an overview of the scientific literature to date on the effects of vaping on respiratory health. Tetrahydrocannabinol was the most commonly vaped substance, and vitamin E acetate was found in BAL specimens from many affected individuals. However, no specific component or contaminant has been identified conclusively to date as the cause for the injury. Patients present with cough, dyspnea, constitutional symptoms, and GI symptoms. Radiologic and histopathologic findings demonstrate a spectrum of nonspecific acute injury patterns. A high index of suspicion combined with a good history are the keys to an accurate diagnosis. Treatment is supportive; the mortality rate is low, and most patients recover. Corticosteroids have been used with apparent success in patients with severe disease, but more rigorous studies are needed to clarify their role in the treatment of vaping-related lung injury.
引用
- Jonas AM, Raj R. Vaping-Related Acute Parenchymal Lung Injury: A Systematic Review. Chest. 2020. PMID: 32442559. doi:10.1016/j.chest.2020.03.085
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。